Medicine and Dentistry
Transcatheter Arterial Chemoembolization
100%
Carmustine
100%
Metastatic Uvea Melanoma
100%
Patient
100%
Liver
100%
Therapeutic Procedure
71%
Neoplasm
42%
Overall Survival
42%
Progression Free Survival
42%
Uveal Melanoma
42%
Lactate Dehydrogenase
42%
Magnetic Resonance Imaging
28%
Follow up
28%
Disease Exacerbation
28%
Liver Metastasis
28%
Diseases
14%
Adverse Event
14%
Toxicity
14%
Metastatic Carcinoma
14%
Elevated Transaminases
14%
Thrombocytopenia
14%
Liver Function
14%
Kidney Function
14%
Liver Parenchyma
14%
Metastatic Melanoma
14%
Age
14%
Hyperbilirubinemia
14%
Response Evaluation Criteria in Solid Tumors
14%
Man
14%
Oncology
14%
INIS
patients
100%
liver
100%
metastases
100%
melanomas
100%
nitrosoureas
100%
levels
57%
tumors
57%
range
57%
diseases
42%
lactate dehydrogenase
42%
nmr imaging
28%
evaluation
14%
computerized tomography
14%
solids
14%
comparative evaluations
14%
performance
14%
men
14%
kidneys
14%
toxicity
14%
cooperatives
14%
inclusions
14%
Nursing and Health Professions
Chemoembolization
100%
Metastatic Uvea Melanoma
100%
Carmustine
100%
Overall Survival
42%
Tumor Volume
42%
Progression Free Survival
42%
Lactate Dehydrogenase
42%
Uvea Melanoma
42%
Follow up
28%
Nuclear Magnetic Resonance Imaging
28%
Disease Exacerbation
28%
Liver Metastasis
28%
Diseases
14%
Adverse Event
14%
Nomenclature
14%
Metastasis
14%
Toxicity
14%
Hyperbilirubinemia
14%
Thrombocytopenia
14%
Imaging
14%
Procedures
14%
Metastatic Melanoma
14%
Response Evaluation Criteria in Solid Tumors
14%
Hypertransaminasemia
14%